These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22825416)

  • 1. Letter by christensen et Al regarding article, "new oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation".
    Christensen TD; Hasenkam JM; Larsen TB
    Circulation; 2012 Jul; 126(4):e45; author reply e46. PubMed ID: 22825416
    [No Abstract]   [Full Text] [Related]  

  • 2. New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation.
    Ansell J
    Circulation; 2012 Jan; 125(1):165-70; discussion 170. PubMed ID: 22215891
    [No Abstract]   [Full Text] [Related]  

  • 3. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.
    Granger CB; Armaganijan LV
    Circulation; 2012 Jan; 125(1):159-64; discussion 164. PubMed ID: 22215890
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on the use of direct oral anticoagulants for the prevention and treatment of thromboembolism.
    Jacobs A; Kabra R; Das P; Oliphant CS
    Future Cardiol; 2018 Jan; 14(1):89-99. PubMed ID: 29226697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ten questions awaiting for a definitive answer on the use of non-vitamin K oral anticoagulants in atrial fibrillation].
    Cemin R; Di Pasquale G; Colonna P; De Caterina R
    G Ital Cardiol (Rome); 2016 Nov; 17(11):884-896. PubMed ID: 27996992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in oral anticoagulation for atrial fibrillation.
    Singh M; Adigopula S; Patel P; Kiran K; Khosla S
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is perioperative bridging anticoagulation useful in patients with atrial fibrillation?
    Fiorelli EM; Podda GM;
    Intern Emerg Med; 2016 Mar; 11(2):249-50. PubMed ID: 26661621
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of article: Perioperative bridging anticoagulation in patients with atrial fibrillation by James D. Douketis, MD, Alex C. Spyropoulos, MD, Scott Kaatz, DO, et al (N Engl J Med 2015;373: 823-833).
    Foley AM
    J Vasc Nurs; 2015 Dec; 33(4):167-8. PubMed ID: 26567057
    [No Abstract]   [Full Text] [Related]  

  • 9. Satisfaction with medical care in patients with atrial fibrillation treated with vitamin K antagonists versus new oral anticoagulants.
    Anguita M; Marín F; Roldán I; Cequier A; Bertomeu V; Muñiz J;
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):537-9. PubMed ID: 25936613
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy in atrial fibrillation].
    Schuchert A
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):1-2. PubMed ID: 24525719
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods of kidney function assessment in non-valvular atrial fibrillation in the era of new oral anticoagulants.
    Andreu-Cayuelas JM; Marín F; Flores-Blanco PJ; García Alberola A; Manzano-Fernández S
    Eur J Intern Med; 2014 Jul; 25(6):e71-2. PubMed ID: 24636781
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
    Lang NN; Connelly DT
    J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once atrial fibrillation, always oral anticoagulation?
    Verheugt FW
    Thromb Res; 2007; 119(3):275-6. PubMed ID: 16426666
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction of Non-Vitamin K Antagonist Anticoagulants Strongly Increased the Rate of Anticoagulation in Hospitalized Geriatric Patients with Atrial Fibrillation.
    Djukic M; Braun LM; Unkel S; Jacobshagen C; Nau R
    Drugs Aging; 2018 Sep; 35(9):859-869. PubMed ID: 30066299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bridging in patients with atrial fibrillation].
    Schinzel H; Nitschmann S
    Internist (Berl); 2015 Oct; 56(10):1209-12. PubMed ID: 26428525
    [No Abstract]   [Full Text] [Related]  

  • 17. Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Vink R; Sohne M; Huisman MV
    N Engl J Med; 2016 Jan; 374(1):91. PubMed ID: 26736006
    [No Abstract]   [Full Text] [Related]  

  • 18. Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Clapin A
    N Engl J Med; 2016 Jan; 374(1):92-3. PubMed ID: 26736009
    [No Abstract]   [Full Text] [Related]  

  • 19. Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Arbit B; Padwal J; Hsu J
    N Engl J Med; 2016 Jan; 374(1):92. PubMed ID: 26736008
    [No Abstract]   [Full Text] [Related]  

  • 20. Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Caldeira D; Costa J; Ferreira JJ
    N Engl J Med; 2016 Jan; 374(1):91-2. PubMed ID: 26736007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.